Long Shen, Ph.D. - Publications
Affiliations: | 2003 | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Cell Biology, Molecular Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2012 | Pankewycz O, Ambrus J, Shen L, Xuan J, Li H, Wu J, Guo LW, Feng L, Laftavi MR. Inhibiting Wipf2 downregulation by transgenic expression of its 3' mRNA-untranslated region improves cytotoxicity and vaccination response. European Journal of Immunology. 42: 2409-18. PMID 22674044 DOI: 10.1002/eji.201141533 | 0.326 | |||
2006 | Kiratiseavee S, Shen L, Baer A, Ambrus J. IL-14 RNA Levels in the Peripheral Blood Leukocytes of Patients with SLE Journal of Allergy and Clinical Immunology. 117: S18. DOI: 10.1016/J.JACI.2005.12.076 | 0.326 | |||
2005 | Chen X, Dudgeon N, Shen L, Wang JH. Chemical modification of gene silencing oligonucleotides for drug discovery and development. Drug Discovery Today. 10: 587-93. PMID 15837602 DOI: 10.1016/S1359-6446(05)03426-4 | 0.615 | |||
2005 | Shen L, Zhang C, Ambrus JL, Wang JH. Silencing of human c-myc oncogene expression by poly-DNP-RNA. Oligonucleotides. 15: 23-35. PMID 15788898 DOI: 10.1089/oli.2005.15.23 | 0.664 | |||
2004 | Chen X, Shen L, Wang JH. Poly-2'-DNP-RNAs with enhanced efficacy for inhibiting cancer cell growth. Oligonucleotides. 14: 90-9. PMID 15294073 DOI: 10.1089/1545457041526326 | 0.661 | |||
2003 | Shen L, Chen X, Wang JH. A high-efficacy antisense RIalpha poly-DNP 21-nt RNA. Antisense & Nucleic Acid Drug Development. 13: 67-74. PMID 12691537 DOI: 10.1089/108729003764097359 | 0.624 | |||
Show low-probability matches. |